TNFRSF11A and prostate cancer: In a different study, the stimulation of the RANKL/RANK or c-Met pathway was found to promote activation of transcription factors related to stem cell-like properties, neuroendocrine differentiation, osteomimicry, and EMT in prostate cancer cells [147].